Bioperfectus launched the first H7N4 avian influenza Real-Time PCR in China. In the same year, Bioperfectus was invited to be the official supplier of infectious disease testing during the "Belt and Road Forum for International Cooperation" in Beijing, China.
During COVID-19 pandemic, Bioperfectus launched COVID-19 Coronavirus Real Time PCR Kit, Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit and Novel Corona Virus (SARS-CoV-2) IgM/IgG Rapid Test, actively assisting the world in fighting against the epidemic.
Since June 2020
Bioperfectus COVID-19 Diagnostic Solution has been distributing to fight against the pandemic all around the world.
In August 2020
Bioperfectus Nucleic Acid Extraction Kit (Magnetic Bead Method), Bioperfectus Nucleic Acid Isolation Kit (Silica Based Spin Coloumn Method), Bioperfectus Nucleic Acid Extraction System (SSNP-2000B, SSNP-3000A, SSNP-9600A) obtained FDA Listed.
On July 9, 2020
Bioperfectus COVID-19 Coronavirus Real Time PCR Kit was granted of World Health Organization Emergency Use Listing (WHO-EUL) .
On June 18, 2020
Bioperfectus COVID-19 Coronavirus Real Time PCR Kit was granted an Emergency Use Authorization by the US Food and Drug Administration(EUA-FDA).
On June 1, 2020
International Sales and Marketing Division was established.
On May 5, 2020
COVID-19 Coronavirus Real Time PCR Kit developed by Bioperfectus was certified by the Australian Drug Administration Therapeutic Goods Administration (TGA);
On March 6, 2020
Bioperfectus COVID-19 Coronavirus Real Time PCR Kit was awarded the CE certification;
a leading molecular diagnostic solution provider